Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immunicon logo — Pioneering cell-based diagnostic solutions to empower physic...

Immunicon

Pioneering cell-based diagnostic solutions to empower physicians with timely and accurate cancer insights.

Founded 1983 Series F Total: $53.75M Biotechnology, Health Care

General Information

Company Name Immunicon
Founded Year 1983
Industries Biotechnology, Health Care
Funding Stage Series F
Social

BounceWatch is an independent company data service, not affiliated with Immunicon. To contact Immunicon, visit immunicon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Immunicon

Immunicon, a pioneer in cell-based diagnostic solutions, is revolutionizing the field of cancer diagnosis and treatment. The company's flagship product, CellTracks, enables the identification, counting, and characterization of tumor cells in blood samples, providing crucial insights to physicians and scientists at an early stage. In 2003, the company received a significant boost with a $24.75M Series F investment from a consortium of prominent investors including Canaan Partners, TL Ventures, Burrill & Company, Wheatley Partners, and Johnson & Johnson Development Corporation. This investment has positioned Immunicon for significant growth and market penetration. With an impressive track record dating back to 1983, Immunicon continues to expand its applications beyond cancer diagnostics, foreseeing opportunities in areas such as cardiovascular and infectious diseases. Teaming up with Veridex, LLC, (a Johnson & Johnson company), the company has demonstrated its commitment to delivering innovative solutions with real-world impact.

Taxonomy: Cell-based diagnostics, Cancer insights, Diagnostic products, Cancer research, Clinical practices, Tumor cell identification, Blood sample analysis, FDA approval process, Collaboration with Johnson & Johnson, Metastatic breast cancer management, Cancer drug development, Cardiovascular diseases, Infectious diseases, Medical technology, Healthcare innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series F $24.75M 5
Canaan Partners TL Ventures Burrill & Company
Canaan Partners, TL Ventures +3
10 Jul 2003
Series F $29.00M -
01 Jun 2001

Immunicon Alternatives & Competitors

Immunicon vs
Sopherion Therapeutics
Sopherion Therapeutics

Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.

Series C
Biotechnology, Health Care
Immunicon vs
Pathwork Diagnostics
Pathwork Diagnostics

Pioneering molecular diagnostics for oncology with the first FDA-cleared microarray-based gene expre...

Venture round
Biotechnology, Health Care
Immunicon vs
Polaris Biology
Polaris Biology China

Meet the next resolution in medicine

Series B
15 employees
Biopharma, Biotechnology
Also compare with: Immunicon vs ANGLE ANGLE

FAQ About Immunicon

Pioneering cell-based diagnostic solutions to empower physicians with timely and accurate cancer insights.
Immunicon was founded in 1983.
Immunicon operates in Biotechnology and Health Care. Its work centres on Cell-based diagnostics, Cancer insights, Diagnostic products and Cancer research.
Immunicon has completed 2 funding rounds, raising a total of $53.75M. The latest funding stage is Series F.
Top alternatives and competitors to Immunicon include Sopherion Therapeutics, Pathwork Diagnostics, Polaris Biology, Adaptive Biotechnologies Corp., ANGLE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunicon and Sopherion Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Immunicon, https://bouncewatch.com/company/immunicon, updated 17 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes